FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests
DA Announces Commissioner’s National Priority Voucher Program (CNPVP)
Related Articles
Tech news: 14 Channels of Data with Compact Wearable
Explore the specifications of the Fibion Vitals, a cutting-edge wearable device designed for comprehensive health monitoring. This episode provides a detaile…
Fibion Sleep Advanced Actigraphy for Sleep & Activity Research – Fibion
Uncover advanced sleep and activity insights with Fibion Sleep. Offering 24-hour data collection, long-lasting battery, and flexible algorithmic analysis for comprehensive research
Updated Release: Hartford Bakery, Inc. Issues Allergy Alert on Undeclared Hazelnuts in “Lewis Bake Shop Artisan Style ½ Loaf”
Hartford Bakery, Inc. is voluntarily recalling six lots of its “Lewis Bake Shop Artisan Style 1/2 Loaf” as this product may contain undeclared hazelnuts. People…
AI Risk Calculator Outperforms EAU Models for Bladder Cancer Prognosis – Alexandre Zlotta
Ashish Kamat is joined by Alexandre Zlotta to discuss the evolution of AI in bladder cancer management. Dr. Zlotta highlights work developing an AI model…
Global Health Overview: Fact Sheet
CDC is America’s first line of defense against global health threats.
Cardiovascular, Reproductive Health Linked to Timing of Menarche
Knowing heightened risks can help women be proactive about health, researcher said
MedCity News Audience Survey 2025
The MedCity News Audience Survey gives readers an opportunity to share their thoughts on the leading online news source for the business of innovation in…
Diabetes Dialogue: ADA 2025 Trials Recap – Part 1
Isaacs and Bellini cover 3 of the most pivotal trial results from the 85th annual American Diabetes Association conference in part 1 of this 2-part…
Determining the Contribution of the Individual Drugs’ Effects
Development of Cancer Drugs for Use in Novel Combination – Determining the Contribution of the Individual Drugs’ Effects
